Nuvilex Announces the Formation of a Diabetes Consortium for the Development of Its Treatment for Insulin-Dependent Diabetes
| Monday, November 24, 2014 7:30 AM |

[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that it has formed a "Diabetes ...

http://us.rd.yahoo.com/finance/news/rss/story...00256.html

~ This Week's OTC News In Review! ~

Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html


~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014